Skip to main content
. Author manuscript; available in PMC: 2014 Jun 6.
Published in final edited form as: Ann Surg Oncol. 2012 Dec 1;20(5):1470–1481. doi: 10.1245/s10434-012-2761-0

FIG. 2.

FIG. 2

a Disease-specific survival (DSS) among all patients with T1/T2 GBCA. b DSS among patients with T1/T2 GBCA treated with R0-resection. Survival analysis did not include two patients with neuroendocrine tumor